SHIELD ProjectFeb 19
The SHIELD project and the EARLYSCAN Cluster were presented during the Early Screening & Hereditary Cancer Awareness Network session at Athens Digital Health Week 🧬
👉 Learn more and read our latest news:
https://missionshield.eu/shield-at-athens-digital-health-week-advancing-cluster-collaboration-in-hereditary-cancer/
#DigitalHealth #HereditaryCancer #EarlyScreening
SHIELD ProjectFeb 5

We’re proud to share the launch of EARLYSCAN, a new European cluster uniting three Horizon Europe projects: SHIELD, DISARM, and PREDI-LYNCH, under the EU Mission on Cancer.

EARLYSCAN brings projects together to align clinical pathways, data standards, and implementation practices — moving from isolated innovation to coordinated, real-world impact.

Read the press release: https://martel-innovate.prowly.com/445670-new-european-project-cluster-earlyscan-launched-to-advance-early-detection-of-heritable-cancers?preview=true

#EARLYSCAN #SHIELD #EarlyDetection #HereditaryCancer

New European Project Cluster EARLYSCAN Launched to Advance Early Detection of Heritable Cancers

A new European collaboration cluster, EARLYSCAN (Early Screening & Hereditary Cancer Awareness Network), has been launched to strengthen prevention and early detection strategies for heritable cancers. The cluster brings together three Horizon Europe–funded projects:...

Martel Innovate - Online Newsroom
Yonhap Infomax NewsNov 11
Kyobo Life Insurance has secured exclusive rights for a new rider covering hereditary female cancer gene and NGS panel tests, marking an industry first in South Korea's insurance sector and expanding personalized cancer care options for women.
#YonhapInfomax #KyoboLifeInsurance #HereditaryCancer #GeneTesting #NGSPanel #ExclusiveRights #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90190
Kyobo Life Secures Exclusive Rights for Hereditary Female Cancer Gene and Panel Test Coverage

Kyobo Life Insurance has secured exclusive rights for a new rider covering hereditary female cancer gene and NGS panel tests, marking an industry first in South Korea's insurance sector and expanding personalized cancer care options for women.

Yonhap Infomax
Stefania VicariJun 5, 2025
💥Are we still social on social media?💥 Hannah Ditchfield and I say yes! We explored #TikTok content about #hereditarycancer and found 3 types of identity work 👇. Part of @leverhulmetrust -funded Previvorship (https://sites.google.com/sheffield.ac.uk/previvorship), out in Social Media+Society: https://journals.sagepub.com/doi/10.1177/20563051251340862